Particella

Developer of gene therapies for gastrointestinal diseases

placeSan Francisco, California, United States calendar_todayFounded 2016 groups4 employees language particella.bio

Registered entities

Innovation

2 patent families — focus: Human necessities; filing pace slowing. Cited 7 times.

YearFilings
20232
20241

Investor mix

9 investors on record; lead investors include IndieBio, Blue Bear Ventures, SOSV, BrightGene.

Investor typeCountShare
Venture capital667%
Accelerator & incubator111%
Other / undisclosed222%
Coming soon